Instead, our most plausible explanation is that patients with an aggressive BC1 more often experienced disease relapse (both ERα-negativity and HIF-1α-positivity are associated with a worse prognosis) before development of a CBC, and hence were excluded from this study. Here, HIF1A is linked to complete blood cell count.